LSE - Delayed Quote GBp

MyHealthChecked PLC (MHC.L)

10.00 0.00 (0.00%)
At close: April 26 at 12:47 PM GMT+1
Key Events
Loading Chart for MHC.L
DELL
  • Previous Close 10.00
  • Open 9.50
  • Bid 9.50 x --
  • Ask 10.50 x --
  • Day's Range 9.50 - 10.16
  • 52 Week Range 8.26 - 29.99
  • Volume 281,629
  • Avg. Volume 92,353
  • Market Cap (intraday) 5.201M
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM)
  • EPS (TTM) 0.00
  • Earnings Date Apr 26, 2024 - Apr 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MyHealthChecked PLC develops and commercializes at-home healthcare and wellness tests in the United Kingdom. It offers nutritional health tests, such as intolerances and sensitivities DNA tests, and vitamins and minerals DNA tests; weight management tests, that includes weight management DNA tests and glucose management DNA tests; and cardiovascular health tests, such as heart profile test DNA test under MyHealthChecked brand. The company also provides MyLotus, a testing strip; and RNA and COVID-19 tests. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked PLC in December 2020. MyHealthChecked PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.

myhealthchecked.com

21

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MHC.L

Performance Overview: MHC.L

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MHC.L
24.53%
FTSE 100
5.26%

1-Year Return

MHC.L
46.67%
FTSE 100
3.15%

3-Year Return

MHC.L
86.39%
FTSE 100
17.31%

5-Year Return

MHC.L
82.22%
FTSE 100
9.49%

Compare To: MHC.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MHC.L

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    5.20M

  • Enterprise Value

    225.59k

  • Trailing P/E

    33.33

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.35

  • Price/Book (mrq)

    0.61

  • Enterprise Value/Revenue

    0.02

  • Enterprise Value/EBITDA

    0.76

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.26%

  • Return on Assets (ttm)

    6.38%

  • Return on Equity (ttm)

    2.22%

  • Revenue (ttm)

    14.95M

  • Net Income Avi to Common (ttm)

    189k

  • Diluted EPS (ttm)

    0.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.01M

  • Total Debt/Equity (mrq)

    0.47%

  • Levered Free Cash Flow (ttm)

    -2.81M

Company Insights: MHC.L

People Also Watch